Growth Hormone Receptor Dimerization & Disulfide Linkage

生长激素受体二聚化

基本信息

  • 批准号:
    8231522
  • 负责人:
  • 金额:
    $ 31.86万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-06-01 至 2015-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Growth hormone (GH), derived largely from the anterior pituitary, regulates postnatal growth and metabolism in vertebrates in an endocrine fashion. Recent studies also suggest roles for autocrine-derived GH and for an intact GH axis in formation and behavior of cancers in animals. GH receptor (GHR) is a cell surface glycoprotein cytokine receptor superfamily member that binds GH in its extracellular domain (ECD) and activates signaling via its intracellular domain's (ICD) interaction with the JAK2 tyrosine kinase. Our recent studies of mechanisms regulating GHR availability and activation reveal exciting insights, including: 1) JAK2 association influences GHR surface presentation, stability, and trafficking; 2) reducing prolactin receptor (PRLR) levels in human T47D breast cancer cells augments GHR abundance and GH sensitivity; 3) novel, conformationally-sensitive anti-GHR ECD antibodies may be useful GH antagonists. We hypothesize: 1) JAK2 expression levels and PRLR expression levels strongly influence GH responsiveness; 2) GH-induced GHR conformational changes that underlie GH signaling are potential targets for therapeutic intervention. Our specific aims are: 1. Determine mechanisms by which JAK2 and PRLR regulate GHR processing, cel surface stability, and downregulation. We will study how GHR predimerization impacts JAK2's modulation of GHR trafficking and the role of GHR ICD tyrosine residues on GH-independent and GH-dependent GHR trafficking. Effects of PRLR expression on GHR availability, GHR-JAK2 association, and GH actions in breast cancer cells will be examined. 2. Determine in vivo efficacy of conformation-specific inhibitory anti-GHR ECD monoclonal antibodies. We will characterize inhibitory properties of two anti-GHR antibodies and Fab fragments in signaling studies, also assessing impact of PRLR expression. We will determine in vivo efficacy of these reagents to antagonize GH signaling and cancer explant growth. These studies probe important determinants of GH sensitivity. Completion will reveal mechanisms regulating cell surface GHR availability and fate and therapeutically relevant tools to modulate GH sensitivity. PUBLIC HEALTH RELEVANCE: Growth hormone is a key regulator of growth and metabolism and recent work suggests that antagonism of growth hormone action may be of therapeutic potential in certain cancers. These studies of the growth hormone receptor investigate the determinants of growth hormone sensitivity at the cellular level. The knowledge gained and the development of inhibitory anti-GH receptor monoclonal antibodies as potential therapeutics may have broad relevance in our understanding of normal physiology and in treatment of cancer.
描述(由申请人提供):生长激素(GH)主要来源于垂体前叶,以内分泌方式调节脊椎动物的出生后生长和代谢。最近的研究也表明,自分泌衍生的生长激素和完整的生长激素轴在动物癌症的形成和行为中的作用。GH受体(GHR)是一种细胞表面糖蛋白细胞因子受体超家族成员,它在细胞外结构域(ECD)结合GH,并通过细胞内结构域(ICD)与JAK2酪氨酸激酶的相互作用激活信号。我们最近对GHR可用性和激活调节机制的研究揭示了令人兴奋的见解,包括:1)JAK2关联影响GHR的表面呈现、稳定性和运输;2)降低人T47D乳腺癌细胞中催乳素受体(PRLR)水平可增加GHR丰度和GH敏感性;3)新的构象敏感的抗ghr ECD抗体可能是有用的GH拮抗剂。我们假设:1)JAK2表达水平和PRLR表达水平强烈影响GH的反应性;2) GH诱导的GHR构象变化是GH信号传导的潜在靶点。我们的具体目标是:1。确定JAK2和PRLR调控GHR加工、细胞表面稳定性和下调的机制。我们将研究GHR预聚如何影响JAK2对GHR转运的调节,以及GHR ICD酪氨酸残基在GHR非依赖型和GHR依赖性GHR转运中的作用。在乳腺癌细胞中,PRLR表达对GHR可用性、GHR- jak2关联和GH作用的影响将被检测。2. 确定构象特异性抑制抗ghr ECD单克隆抗体的体内疗效。我们将在信号研究中表征两种抗ghr抗体和Fab片段的抑制特性,并评估PRLR表达的影响。我们将确定这些试剂在体内拮抗生长激素信号和肿瘤外植体生长的功效。这些研究探讨了生长激素敏感性的重要决定因素。完成将揭示调节细胞表面GHR可用性和命运的机制以及调节GH敏感性的治疗相关工具。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stuart J Frank其他文献

Stuart J Frank的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stuart J Frank', 18)}}的其他基金

Relationship between circadian disruption, cardiac GH/IGF-1 signaling, and heart failure
昼夜节律紊乱、心脏 GH/IGF-1 信号传导与心力衰竭之间的关系
  • 批准号:
    9349692
  • 财政年份:
    2017
  • 资助金额:
    $ 31.86万
  • 项目类别:
Relationship between circadian disruption, cardiac GH/IGF-1 signaling, and heart failure
昼夜节律紊乱、心脏 GH/IGF-1 信号传导与心力衰竭之间的关系
  • 批准号:
    9898294
  • 财政年份:
    2017
  • 资助金额:
    $ 31.86万
  • 项目类别:
Relationship between circadian disruption, cardiac GH/IGF-1 signaling, and heart failure
昼夜节律紊乱、心脏 GH/IGF-1 信号传导与心力衰竭之间的关系
  • 批准号:
    10321881
  • 财政年份:
    2017
  • 资助金额:
    $ 31.86万
  • 项目类别:
A Novel Role for IGF-1 Receptor in Growth Hormone Action
IGF-1 受体在生长激素作用中的新作用
  • 批准号:
    9178068
  • 财政年份:
    2015
  • 资助金额:
    $ 31.86万
  • 项目类别:
GH Receptor Proteolysis and Shedding
GH 受体蛋白水解和脱落
  • 批准号:
    8597925
  • 财政年份:
    2012
  • 资助金额:
    $ 31.86万
  • 项目类别:
GH Receptor Proteolysis and Shedding
GH 受体蛋白水解和脱落
  • 批准号:
    8963445
  • 财政年份:
    2012
  • 资助金额:
    $ 31.86万
  • 项目类别:
GH Receptor Proteolysis and Shedding
GH 受体蛋白水解和脱落
  • 批准号:
    8332469
  • 财政年份:
    2012
  • 资助金额:
    $ 31.86万
  • 项目类别:
Growth Hormone Receptor Dimerization & Disulfide Linkage
生长激素受体二聚化
  • 批准号:
    8619614
  • 财政年份:
    2011
  • 资助金额:
    $ 31.86万
  • 项目类别:
Growth Hormone Receptor Dimerization & Disulfide Linkage
生长激素受体二聚化
  • 批准号:
    8434948
  • 财政年份:
    2011
  • 资助金额:
    $ 31.86万
  • 项目类别:
Growth Hormone Receptor Dimerization & Disulfide Linkage
生长激素受体二聚化
  • 批准号:
    8042450
  • 财政年份:
    2011
  • 资助金额:
    $ 31.86万
  • 项目类别:

相似海外基金

How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.86万
  • 项目类别:
    Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 31.86万
  • 项目类别:
    Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 31.86万
  • 项目类别:
    Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.86万
  • 项目类别:
    Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 31.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 31.86万
  • 项目类别:
    Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 31.86万
  • 项目类别:
    Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 31.86万
  • 项目类别:
    Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
  • 批准号:
    23K00129
  • 财政年份:
    2023
  • 资助金额:
    $ 31.86万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
  • 批准号:
    2883985
  • 财政年份:
    2023
  • 资助金额:
    $ 31.86万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了